136 related articles for article (PubMed ID: 9576368)
21. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
22. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
23. Effects of nitric oxide syntase inhibitor on exercise-mediated pro- and anti-oxidative balance in rat blood plasma.
Frankiewicz-Jóźko A; Grudziński IP
Rocz Panstw Zakl Hig; 2005; 56(4):339-45. PubMed ID: 16610670
[TBL] [Abstract][Full Text] [Related]
24. The inhibition of nitric oxide synthase suppresses LPS- and psychological-stress-induced fever in rats.
Soszynski D
Physiol Behav; 2001 Jan; 72(1-2):65-72. PubMed ID: 11239982
[TBL] [Abstract][Full Text] [Related]
25. The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis.
Hsiao CC; Lee CH; Tsao LY; Lo HC
PLoS One; 2012; 7(8):e42467. PubMed ID: 22879994
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant effect of N omega-nitro-L-arginine methyl ester (L-NAME) on global cerebral ischemia in a rat model.
Seif-el-Nasr M; Fahim AT
Arzneimittelforschung; 2001; 51(8):628-32. PubMed ID: 11556122
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effects of N omega-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro.
Ayers NA; Kapás L; Krueger JM
Neurochem Res; 1997 Jan; 22(1):81-6. PubMed ID: 9021767
[TBL] [Abstract][Full Text] [Related]
28. Behavioural, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats.
Prickaerts J; De Vente J; Markerink-Van Ittersum M; Steinbusch HW
Neuroscience; 1998 Nov; 87(1):181-95. PubMed ID: 9722151
[TBL] [Abstract][Full Text] [Related]
29. Oxygen radicals and nitric oxide in rat mesenteric ischaemia-reperfusion: modulation by L-arginine and NG-nitro-L-arginine methyl ester.
Haklar G; Ulukaya-Durakbaşa C; Yüksel M; Dağli T; Yalçin AS
Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):908-12. PubMed ID: 9807662
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle and jejunal protein synthesis in normal and ethanol-treated rats: the effect of the nitric oxide synthase inhibitors, L-omega-nitro-L-arginine methyl ester and N(G)-nitro-L-arginine in vivo.
Rajendram R; Marway JS; Mantle D; Peters TJ; Preedy VR
Metabolism; 2003 Apr; 52(4):397-401. PubMed ID: 12701048
[TBL] [Abstract][Full Text] [Related]
31. Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine.
Yorganci K; Sayek I; Ismailoglu UB; Sahin-Erdemli I
Eur J Surg; 2000 Nov; 166(11):888-93. PubMed ID: 11097157
[TBL] [Abstract][Full Text] [Related]
32. Exercise-induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with N(G)-nitro-L-arginine methyl ester in humans.
Frandsenn U; Bangsbo J; Sander M; Höffner L; Betak A; Saltin B; Hellsten Y
J Physiol; 2001 Feb; 531(Pt 1):257-64. PubMed ID: 11179408
[TBL] [Abstract][Full Text] [Related]
33. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion.
Gross R; Roye M; Manteghetti M; Broca C; Hillaire-Buys D; Masiello P; Ribes G
Br J Pharmacol; 1997 Feb; 120(3):495-501. PubMed ID: 9031755
[TBL] [Abstract][Full Text] [Related]
35. Different mechanisms underlie the effects of acute and long-term inhibition of nitric oxide synthases in antigen-induced pulmonary eosinophil recruitment in BALB/C mice.
Lintomen L; Souza-Filho LG; Ferreira T; Camargo EA; Teixeira SA; Muscará MN; Landgraf RG; Jancar S; Mendes GD; De Nucci G; Antunes E
Pulm Pharmacol Ther; 2009 Feb; 22(1):1-8. PubMed ID: 19010435
[TBL] [Abstract][Full Text] [Related]
36. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
37. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
38. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge.
Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y
Pharmacol Toxicol; 2000 Apr; 86(4):162-8. PubMed ID: 10815749
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide synthesis inhibition modifies the cardiotoxicity of tetracaine and lidocaine.
Heavner JE; Shi B; Pitkänen M
Anesth Analg; 1999 Apr; 88(4):717-22. PubMed ID: 10195510
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide production in peritoneal macrophages from peritoneal dialysis patients with bacterial peritonitis.
Plum J; Tabatabaei MM; Lordnejad MR; Pipinika O; Razeghi P; Huang C; Meyer-Kirchrath J; Grabensee B
Perit Dial Int; 1999; 19 Suppl 2():S378-83. PubMed ID: 10406550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
